Module EW4250-KP06

Clinical Studies 2 (Design and Analysis) (DDKS)


Duration

1 Semester

Turnus of offer

each summer semester

Credit points

6

Course of studies, specific fields and terms:

  • Master Nutritional Medicine 2023, compulsory, interdisciplinary competence
  • Master Nutritional Medicine 2019, compulsory, interdisciplinary competence

Classes and lectures:

  • Design and realization of clinical studies (exercise, 1 SWS)
  • Design and realization of clinical studies (seminar, 1 SWS)
  • Design and realization of clinical studies (lecture, 2 SWS)

Workload:

  • 90 hours private studies
  • 60 hours in-classroom work

Contents of teaching:

  • What is a clinical trial – Definitions/ Examples
  • Different types of trial
  • Ethical issues.
  • Blindness.
  • Planning the trial: formulation of hypotheses.
  • Explanatory and pragmatic approaches: clinical trials as hypothesis testing and decision procedures.
  • Choice of outcome measures and implications for analysis.
  • Selecting patient populations and samples.
  • Obtaining and maintaining comparable patient groups: selection, allocation and assessment biases and their avoidance.
  • Allocation to treatment: simple, restricted and stratified randomisation; minimisation
  • Extensions: cluster randomised trials, crossover trials, equivalence trials, factorial trials and meta-analysis.
  • Introduction to Phase 2-3 Designs
  • Trial Critiques.
  • Superiority and non-inferiority trials
  • CV-outcome studies (endpoint studies) vs. safety trials
  • Drug regulatory perspectives on clinical trial design, conduct, analysis and interpretation
  • Design and analysis issues in crossover trial designs
  • Design and analysis issues in cluster trial designs
  • Meta-analysis of clinical trial data
  • Inclusion of economic evaluation in or with trial designs
  • An introduction to personalised medicine

Qualification-goals/Competencies:

  • Students are able to understand the principles and rationale of clinical trial design and conduct
  • The students can appreciate some special problems of analysis and interpretation of clinical trials results, and the ways in which good experimental design can help avoid these
  • Students can appreciate the ethical and regulatory issues surrounding clinical trials & their use in health technology assessment
  • They understand specific design issues in clinical trials, including; inclusion/exclusion criteria, blinding, and randomisation
  • They understand and calculate the sample size required for a clinical trial
  • They are able to carry out an extended piece of statistical analysis using computer software
  • They can summarise and interpret the results of a statistical analysis for both a technical and non-technical audience
  • They learn to deal with real and difficult analysis issues and to appreciate no single “correct” solutions exist
  • They have a practical understanding of the methods covered in Clinical Trials

Grading through:

  • portfolio exam

Responsible for this module:

  • PD Dr. Britta Wilms

Teacher:

  • Institute for Experimental Endocrinology
  • MitarbeiterInnen des Instituts
  • PD Dr. Britta Wilms
  • Dr. Marcel Pointke

Literature:

  • Brody, T : Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines Elsevier
  • Friedman, L.M., Furberg, C.D., DeMets, D.L : Fundamentals of Clinical Trials Springer

Language:

  • German and English skills required

Notes:

Admission requirements for taking the module:
- None (the competences of the modules listed under 'requires' are needed for this module, but are not a formal prerequisite).

Admission requirements for taking module examination(s):
- SoSe 2021: no prerequisites
- from SoSe 2022: active participation in the exercises in small groups as specified at the beginning of the semester

Module exam(s):
- EW4250-L1: Clinical Studies 2, portfolio exam consisting of: 40 points in the form of seminar paper/excersises and 60 points in the form of a written exam, 100% of the module grade


(Share of Nutritional Medicine in V is 100%)
(Share of Nutritional Medicine in S is 100%)
(Share of Nutritional Medicine in Ü is 100%)

Last Updated:

27.03.2024